TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) SEC Filings & Financial Intelligence
TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) is a publicly traded company on the NYSE, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TEVA
CIK: 818686
Exchange: NYSE
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: L3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Kesselman & Kesselman C.P.A.s
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerChad Mueller
Audit LocationTel-Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-11-06 | 2026-11-05 | 4 | 0001193125-26-451814 | View SEC Doc Filr Page |
| 4 | 2026-11-06 | 2026-11-04 | 4 | 0001193125-26-451804 | View SEC Doc Filr Page |
| 144 | 2026-11-05 | — | 144 Filing | 0001973379-26-000362 | View SEC Doc Filr Page |
| 144 | 2026-11-04 | — | 144 Filing | 0001973379-26-000356 | View SEC Doc Filr Page |
| 10-Q | 2026-11-03 | 2026-09-30 | 10-Q | 0000818686-26-000006 | View SEC Doc Filr Page |
| 8-K | 2026-11-03 | 2026-11-03 | FORM 8-K | 0001171843-26-007054 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-11-02 | — | SCHEDULE 13G/A Filing | 0001178913-26-004925 | View SEC Doc Filr Page |
| 8-K | 2026-10-29 | 2026-10-27 | 8-K | 0001193125-26-438019 | View SEC Doc Filr Page |
| 3 | 2026-10-08 | 2026-09-29 | 3 | 0001193125-26-417902 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-18 | 4 | 0001193125-26-398105 | View SEC Doc Filr Page |
| 4 | 2026-09-22 | 2026-09-19 | 4 | 0001193125-26-397959 | View SEC Doc Filr Page |
| 144 | 2026-09-21 | — | 144 Filing | 0001973379-26-000342 | View SEC Doc Filr Page |
| 144 | 2026-09-18 | — | 144 Filing | 0000919574-26-006400 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-16 | 8-K | 0001193125-26-393116 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-14 | 8-K | 0001193125-26-390562 | View SEC Doc Filr Page |
| 8-A12B/A | 2026-09-14 | — | 8-A12B/A | 0001193125-26-390559 | View SEC Doc Filr Page |
| 25-NSE | 2026-09-14 | — | 25-NSE Filing | 0000876661-26-000744 | View SEC Doc Filr Page |
| 424B5 | 2026-09-11 | — | 424B5 | 0001193125-26-389382 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-09 | 8-K | 0001193125-26-389264 | View SEC Doc Filr Page |
| FWP | 2026-09-10 | — | FWP | 0001193125-26-387112 | View SEC Doc Filr Page |
| FWP | 2026-09-10 | — | FWP | 0001193125-26-387100 | View SEC Doc Filr Page |
| 424B5 | 2026-09-08 | — | 424B5 | 0001193125-26-384343 | View SEC Doc Filr Page |
| 8-K | 2026-09-03 | 2026-09-03 | 8-K | 0001193125-26-381899 | View SEC Doc Filr Page |
| 8-K | 2026-09-03 | 2026-08-31 | 8-K | 0001193125-26-381879 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | 4 | 0001193125-26-365116 | View SEC Doc Filr Page |